[HTML][HTML] Oxidative stress and redox-modulating therapeutics in inflammatory bowel disease
AR Bourgonje, M Feelisch, KN Faber, A Pasch… - Trends in molecular …, 2020 - cell.com
Inflammatory bowel disease (IBD) is associated with the production of reactive species that
target cysteine redox switches in proteins, thereby affecting gene regulation, DNA damage …
target cysteine redox switches in proteins, thereby affecting gene regulation, DNA damage …
Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease
AR Bourgonje, M Feelisch, KN Faber… - Trends in …, 2020 - pubmed.ncbi.nlm.nih.gov
Inflammatory bowel disease (IBD) is associated with the production of reactive species that
target cysteine redox switches in proteins, thereby affecting gene regulation, DNA damage …
target cysteine redox switches in proteins, thereby affecting gene regulation, DNA damage …
[PDF][PDF] Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease
AR Bourgonje, M Feelisch, KN Faber… - Trends in Molecular …, 2020 - researchgate.net
Inflammatory bowel disease (IBD) is associated with the production of reactive species that
target cysteine redox switches in proteins, thereby affecting gene regulation, DNA damage …
target cysteine redox switches in proteins, thereby affecting gene regulation, DNA damage …
[HTML][HTML] Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease
AR Bourgonje, M Feelisch, KN Faber, A Pasch… - Trends in Molecular …, 2020 - Elsevier
HighlightsOxidative stress is a key feature of Inflammatory Bowel Disease (IBD). However,
there is still insufficient understanding of the redox architecture that defines the pathogenic …
there is still insufficient understanding of the redox architecture that defines the pathogenic …
Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease.
AR Bourgonje, M Feelisch, KN Faber… - Trends in Molecular …, 2020 - europepmc.org
Inflammatory bowel disease (IBD) is associated with the production of reactive species that
target cysteine redox switches in proteins, thereby affecting gene regulation, DNA damage …
target cysteine redox switches in proteins, thereby affecting gene regulation, DNA damage …
[PDF][PDF] Oxidative Stress and Redox-Modulating Therapeutics in lnflammatory Bowel Disease
G Dijkstra, H van Goor - core.ac.uk
Inflammatory bowel disease (IBD) is associated with the production of reactive species that
target cysteine redox switches in proteins, thereby affecting gene regulation, DNA damage …
target cysteine redox switches in proteins, thereby affecting gene regulation, DNA damage …
[引用][C] Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease
AR Bourgonje, M Feelisch, KN Faber, A Pasch… - Trends in Molecular …, 2020 - cir.nii.ac.jp
Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Oxidative stress and Redox-Modulating Therapeutics in inflammatory bowel disease
AR Bourgonje, M Feelisch, KN Faber… - Trends in Molecular …, 2020 - eprints.soton.ac.uk
Inflammatory bowel disease (IBD) is associated with the production of reactive species that
target cysteine redox switches in proteins, thereby affecting gene regulation, DNA damage …
target cysteine redox switches in proteins, thereby affecting gene regulation, DNA damage …
Oxidative Stress and Redox-Modulating Therapeutics in Inflammatory Bowel Disease
AR Bourgonje, M Feelisch, KN Faber… - Trends in Molecular …, 2020 - research.rug.nl
Inflammatory bowel disease (IBD) is associated with the production of reactive species that
target cysteine redox switches in proteins, thereby affecting gene regulation, DNA damage …
target cysteine redox switches in proteins, thereby affecting gene regulation, DNA damage …